IDENTIFICATION OF MOLECULAR TARGETS ASSOCIATED WITH TRANSFORMED DIFFUSE LARGE B CELL LYMPHOMA USING HIGHLY PURIFIED TUMOUR CELLS - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue American Journal of Hematology Année : 2009

IDENTIFICATION OF MOLECULAR TARGETS ASSOCIATED WITH TRANSFORMED DIFFUSE LARGE B CELL LYMPHOMA USING HIGHLY PURIFIED TUMOUR CELLS

Ulrika Andreasson
  • Fonction : Auteur
  • PersonId : 879627
Michael Dictor
  • Fonction : Auteur
  • PersonId : 879628
Mats Jerkeman
  • Fonction : Auteur
  • PersonId : 879629
Mattias Berglund
  • Fonction : Auteur
  • PersonId : 879630
Christer Sundström
  • Fonction : Auteur
  • PersonId : 879631
Johan Linderoth
  • Fonction : Auteur
  • PersonId : 879632
Richard Rosenquist
  • Fonction : Auteur
  • PersonId : 879633
Carl A.K Borrebaeck
  • Fonction : Auteur
  • PersonId : 879634
Sara Ek
  • Fonction : Auteur correspondant
  • PersonId : 879635

Connectez-vous pour contacter l'auteur

Résumé

Introduction: Follicular lymphoma (FL) frequently transforms into the more aggressive diffuse large B cell lymphoma (DLBCL-tr) but no protein biomarkers have been identified for predictive or early diagnosis. Gene expression analyses have identified genes changing upon transformation but have failed to be reproducible in different studies, reflecting the heterogeneity within the tumor tissue and between tumor samples. Material and Methods: Gene expression analyses on Affymetrix Human Genome U133 Plus 2.0 arrays were performed, using flow cytometry sorted tumor cells derived from FL and transformed DLBCL. To identify molecular targets associated with the transformation, subsequent immunohistochemistry (IHC) analyses of the corresponding proteins were performed. Results: Using highly purified cells, this study identified 163 genes, which were significantly deregulated during the transformation in a majority of cases. Among the upregulated transcripts, 13 genes were selected for validation using IHC, based on the availability of commercial antibodies, and galectin-3 and NEK2 proteins specifically identify DLBCL-tr, as compared to FL. Conclusion: We demonstrate that by purifying tumor cells through cell sorting, thereby reducing the heterogeneity due to infiltrating cells, it was possible to identify distinct differences between tumor entities rather than variations due to cellular composition. Galectin-3 and NEK2 both identified a subgroup of DLBCL-tr, and the function of these protein markers also suggests a biological role in the transformation process.

Mots clés

Fichier principal
Vignette du fichier
PEER_stage2_10.1002%2Fajh.21549.pdf (1.54 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-00520635 , version 1 (24-09-2010)

Identifiants

Citer

Ulrika Andreasson, Michael Dictor, Mats Jerkeman, Mattias Berglund, Christer Sundström, et al.. IDENTIFICATION OF MOLECULAR TARGETS ASSOCIATED WITH TRANSFORMED DIFFUSE LARGE B CELL LYMPHOMA USING HIGHLY PURIFIED TUMOUR CELLS. American Journal of Hematology, 2009, 84 (12), pp.803. ⟨10.1002/ajh.21549⟩. ⟨hal-00520635⟩

Collections

PEER
38 Consultations
55 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More